Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The skeletal muscle nicotinic acetylcholine receptor is a ligand-gated ion channel found at the neuromuscular junction and is the key mediator of fast synaptic transmission between motor neurons and skeletal muscle fibers. It is a heteropentameric protein complex typically composed of two α1, one β1, one δ, and one ε (adult) or γ (fetal) subunits. Upon binding two molecules of acetylcholine released from motor neurons, the receptor undergoes a conformational change that opens its ion channel pore, allowing rapid influx of sodium ions and efflux of potassium ions, initiating muscle membrane depolarization and triggering muscle contraction. It is essential for voluntary movement, and its malfunction or blockade is linked to pathologies such as myasthenia gravis, congenital myasthenic syndromes, and paralysis by neurotoxins or clinical muscle relaxants[1][3][5][8][9].
Agonists open the ion channel to allow cation influx (mainly Na^+, some K^+, and Ca^2+^), leading to depolarization and muscle contraction; Antagonists compete for the acetylcholine binding site (competitive block) or bind irreversibly (non-competitive, e.g., alpha-bungarotoxin), leading to muscle relaxation or paralysis[1][5][6][9].
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Skeletal muscle nicotinic acetylcholine receptor (nAChR (muscle-type), or muscle-type nAChR).